[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-340225-105":3,"doc-detail-340225-en":80,"detail-sidebar-cat-0-en-105":115},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":73,"head_meta":75,"extra_data":77,"updated_unix":79},105,"en","spatial-analyses-revealed-s100p-tff1-tumor-cells-in-spread-through-air-spaces-samples-correlated-with-undesirable-therapy-response-in-non-small-cell-lung-cancer","Spatial analyses revealed S100P + TFF1 + tumor cells in spread through air spaces samples correlated with undesirable therapy response in non-small cell lung cancer","","Spread through air spaces (STAS) is a recognized aggressive pattern in lung cancer and a key risk factor for postoperative recurrence, yet its phenotype and spatial structure remain unclear. A comprehensive spatial-data study analyzed over 30,000 spots from 14 non-STAS and 1 STAS sample, showing increased proliferation and angiogenesis in STAS and identifying S100P as a candidate biomarker. STAS tumor-cell heterogeneity revealed an S100P + TFF1 + subset with worse survival and high TGFβ- and hypoxia-related activity. This subtype associated with poorer responses to EGFR-TKI and immunotherapy, with TFF1 as a serum predictor for EGFR-TKI response. Cell-cell communication analysis indicated TGFβ signaling as most activated, validated by multiplex immunofluorescence.",{"@graph":14,"@context":72},[15,34,55],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/spatial-analyses-revealed-s100p-tff1-tumor-cells-in-spread-through-air-spaces-samples-correlated-with-undesirable-therapy-response-in-non-small-cell-lung-cancer/340225/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/spatial-analyses-revealed-s100p-tff1-tumor-cells-in-spread-through-air-spaces-samples-correlated-with-undesirable-therapy-response-in-non-small-cell-lung-cancer/340225.png","ImageObject",300,407,{"name":42,"@type":43},"River Wang","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-15","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":33},"InteractionCounter",{"@type":54},"ViewAction",{"@type":56,"mainEntity":57},"FAQPage",[58,64,68],{"name":59,"@type":60,"acceptedAnswer":61},"What is the main focus of the study on STAS in lung cancer?","Question",{"text":62,"@type":63},"The study investigates the phenotype and spatial structure of spread through air spaces (STAS), and how specific STAS tumor-cell subsets relate to therapy outcomes.","Answer",{"name":65,"@type":60,"acceptedAnswer":66},"Which biomarker is identified as a potential marker for STAS?",{"text":67,"@type":63},"S100P is identified as a potential biomarker for STAS based on spatial analyses and related observations.",{"name":69,"@type":60,"acceptedAnswer":70},"How do S100P + TFF1 + tumor cells affect therapy response?",{"text":71,"@type":63},"The presence of S100P + TFF1 + tumor cells correlates with worse responses to both EGFR-TKI therapy and immunotherapy. TFF1 is reported as a serum marker for predicting EGFR-TKI response.","https://schema.org",{"og:url":32,"og:type":74,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":76,"canonical":32},"index,follow",{"doc_id":78,"site_id":7},340225,1790951970,{"code":4,"msg":81,"data":82},"success",{"doc_id":78,"user_id":83,"nickname":42,"user_avatar":84,"doc_module":4,"category_id":85,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":86,"file_id":87,"file_url":88,"file_type":89,"file_size":90,"view_count":33,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":91,"language":92,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":93,"faqs":94,"seo_title":95,"seo_description":12,"update_tm":96,"read_time":97,"preview_page_count":33,"preview_urls":98},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542",8,"Fan etal. Journal of Translational Medicine (2024) 22:917  \n[https://doi.org/10.1186/s12967-024-05722-6](https://doi.org/10.1186/s12967-024-05722-6)  \nJournal of Translational Medicine  \n RESEARCH Open Access  \nSpatial analyses revealed  \nS100P +TFF1+tumor cells in spread through air spaces samples correlated with undesirable therapy response in non-small cell lung cancer  \nGuangyu Fan1†, Tongji Xie1†, Mengwei Yang1†, Lin Li2, Le Tang1, Xiaohong Han3* and Yuankai Shi1*  \nAbstract  \nSpread through air spaces (STAS) is a recognized aggressive pattern in lung cancer, serving as a crucial risk factor for postoperative recurrence. However, its phenotype and related spatial structure have remained elusive. To address these limitations, we conducted a comprehensive study based on spatial data, analyzing over 30,000 spots from 14 non-STAS samples and one STAS sample. We observed increased proliferation activities and angiogenesis in STAS, identifying S100P as a potential biomarker for STAS. Furthermore, our investigation into the heterogeneity of STAS tumor cells revealed a subset identified as S100P + TFF1 +, exhibiting a negative impact on patients’ survival in public datasets. This subtype exhibited the highest activities in theTGFb and hypoxia, suggesting its potential pro-tumor role within the tumor microenvironment. To assess the role of S100P + TFF1 + tumor cells in therapy response, we included data from two clinical trial cohorts (BPI-7711 for EGFR-TKI therapy and ORIENT-3 for immunotherapy) . The presence of S100P + TFF1 + tumor cells correlated with worse responses to both EGFR-TKI therapy and immunotherapy. Notably, TFF1 emerged as a serum marker for predicting EGFR-TKI response. Cell–cell communication analysis revealed that the TGFb signaling pathway was the most activated in S100P + TFF1 + tumor cells, with TGFB2-TGFBR2 identified as the main ligand-receptor pair. This was further validated by multiplex immunofluorescence performed on twenty NSCLC samples. In summary, our study identified S100P as the biomarker for STAS and highlighted the adverse role of S100P + TFF1 + tumor cells in survival outcomes.  \nKeywords Spread through air spaces, Non-small cell lung cancer, Spatial patterns, Spatial transcriptomics  \n†Guangyu Fan, Tongji Xie and Mengwei Yang have contributed equally to this work.  \n*Correspondence: Xiaohong Han [hanxiaohong@pumch.cn](hanxiaohong@pumch.cn)[ ](hanxiaohong@pumch.cn)Yuankai Shi[syuankai@cicams.ac.cn](syuankai@cicams.ac.cn)  \n1 Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, No.  \n17 Panjiayuan Nanli, Chaoyang District, Beijing 100021, China  \n2 Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China  \n3 Clinical Pharmacology Research Center, Peking Union Medical College Hospital, State Key Laboratory of Complex Severe and Rare Diseases, NMPA Key Laboratory for Clinical Research and Evaluation of Drug, Beijing Key Laboratory of Clinical PK & PD Investigation for Innovative Drugs, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 1, Shuaifuyuan, Dongcheng District, Beijing 100730, China  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of","cbCail5OK1JNNN1s","https://ap.wps.com/l/cbCail5OK1JNNN1s","pdf",8559405,18,"English","# Abstract\n# Introduction","[{\"question\":\"What is the main focus of the study on STAS in lung cancer?\",\"answer\":\"The study investigates the phenotype and spatial structure of spread through air spaces (STAS), and how specific STAS tumor-cell subsets relate to therapy outcomes.\"},{\"question\":\"Which biomarker is identified as a potential marker for STAS?\",\"answer\":\"S100P is identified as a potential biomarker for STAS based on spatial analyses and related observations.\"},{\"question\":\"How do S100P + TFF1 + tumor cells affect therapy response?\",\"answer\":\"The presence of S100P + TFF1 + tumor cells correlates with worse responses to both EGFR-TKI therapy and immunotherapy. TFF1 is reported as a serum marker for predicting EGFR-TKI response.\"}]","Spatial analyses revealed S100P + TFF1 + tumor cells in spread through air spaces samples correlated with undesirable therapy response in non-small cell lung cancer | PDF",1790035030,45,[99,103,107,111],{"page_no":22,"url":100,"width":101,"height":102},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4042325b48033b89b87fb3c9edc3459d.webp",983,1305,{"page_no":26,"url":104,"width":105,"height":106},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4ebe3740485d12dc6f57725ec01892c7.webp",982,1304,{"page_no":30,"url":108,"width":109,"height":110},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/edf5b427ed639f8ddfa0d618c29572f0.webp",981,1303,{"page_no":33,"url":112,"width":113,"height":114},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/77409a1fa94e6e0a03d5867cf328efc6.webp",980,1301,{"code":4,"msg":81,"data":116},[117,121,125,129,134,139,144,147,152,155,159],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":118,"show_sort_weight":119,"slug":120},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":122,"show_sort_weight":123,"slug":124},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":126,"show_sort_weight":127,"slug":128},"Exam",70,"exam",{"id":130,"doc_module":4,"doc_module_name":25,"category_name":131,"show_sort_weight":132,"slug":133},5,"Comic",60,"comic",{"id":135,"doc_module":4,"doc_module_name":25,"category_name":136,"show_sort_weight":137,"slug":138},6,"Technology",50,"technology",{"id":140,"doc_module":4,"doc_module_name":25,"category_name":141,"show_sort_weight":142,"slug":143},7,"Healthcare",40,"healthcare",{"id":85,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":145,"slug":146},30,"research-report",{"id":148,"doc_module":4,"doc_module_name":25,"category_name":149,"show_sort_weight":150,"slug":151},9,"Religion & Spirituality",20,"religion-spirituality",{"id":150,"doc_module":4,"doc_module_name":25,"category_name":153,"show_sort_weight":150,"slug":154},"World Cup","world-cup",{"id":156,"doc_module":4,"doc_module_name":25,"category_name":157,"show_sort_weight":156,"slug":158},10,"Lifestyle","lifestyle",{"id":160,"doc_module":4,"doc_module_name":25,"category_name":161,"show_sort_weight":130,"slug":162},19,"General","general"]